Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
1 Am J Surg |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Should breast surgery be considered for patients with de novo metastatic
inflammatory breast cancer?
Am J Surg. 2024 Mar 2:S0002-9610(24)00068-0. doi: 10.1016/j.amjsurg.2024.
PubMed
Abstract available
Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative
breast cancer: Does it help tailor adjuvant treatment?
Ann Oncol. 2024 Mar 12:S0923-7534(24)00077-2. doi: 10.1016/j.annonc.2024.
PubMed
Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local
Excision of Non-palpable Breast Cancer.
Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15142.
PubMed
Abstract available
Role of beta-(1-->3)(1-->6)-D-glucan derived from yeast on natural killer (NK) cells
and breast cancer cell lines in 2D and 3D cultures.
BMC Cancer. 2024;24:339.
PubMed
Abstract available
Impact of timing and format of patient decision aids for breast cancer patients
on their involvement in and preparedness for decision making - the IMPACTT
randomised controlled trial protocol.
BMC Cancer. 2024;24:336.
PubMed
Abstract available
Neuropilin-1 and placental growth factor as prognostic factors in metastatic
breast cancer.
BMC Cancer. 2024;24:331.
PubMed
Abstract available
Validation of primary and outcome data quality in a Swedish population-based
breast cancer quality registry.
BMC Cancer. 2024;24:329.
PubMed
Abstract available
Long-term trends in incidence, characteristics and prognosis of screen-detected
and interval cancers in women participating in the Dutch breast cancer screening
programme.
Br J Cancer. 2024 Mar 11. doi: 10.1038/s41416-024-02633.
PubMed
Abstract available
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and
patient-reported outcomes measured with 15 years follow-up: the CHARM cohort
profile.
Breast Cancer. 2024 Mar 12. doi: 10.1007/s12282-024-01559.
PubMed
Abstract available
Enhancing radiosensitivity in triple-negative breast cancer through targeting
ELOB.
Breast Cancer. 2024 Mar 12. doi: 10.1007/s12282-024-01554.
PubMed
Abstract available
The role of the BTLA-HVEM complex in the pathogenesis of breast cancer.
Breast Cancer. 2024 Mar 14. doi: 10.1007/s12282-024-01557.
PubMed
Abstract available
Tissue Engineering Scaffolds Loaded With a Variety of Plant Extracts: Novel Model
in Breast Cancer Therapy.
Breast Cancer (Auckl). 2024;18:11782234241236358.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage
Tube Retention Time in Patients with Breast Cancer Surgery.
Breast Cancer (Dove Med Press). 2024;16:91-103.
PubMed
Abstract available
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the
Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World
Setting.
Breast Cancer (Dove Med Press). 2024;16:105-116.
PubMed
Abstract available
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients.
Breast Cancer (Dove Med Press). 2024;16:117-126.
PubMed
Abstract available
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer.
Breast Cancer (Dove Med Press). 2024;16:71-89.
PubMed
Abstract available
The FBXW7-binding sites on FAM83D are potential targets for cancer therapy.
Breast Cancer Res. 2024;26:37.
PubMed
Abstract available
Detection of HER2 expression using (99m)Tc-NM-02 nanobody in patients with breast
cancer: a non-randomized, non-blinded clinical trial.
Breast Cancer Res. 2024;26:40.
PubMed
Abstract available
UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast
cancer by deubiquitinating and stabilizing KLF5.
Breast Cancer Res. 2024;26:44.
PubMed
Abstract available
HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are
they connected?
Breast Cancer Res. 2024;26:41.
PubMed
Abstract available
Cell morphology best predicts tumorigenicity and metastasis in vivo across
multiple TNBC cell lines of different metastatic potential.
Breast Cancer Res. 2024;26:43.
PubMed
Abstract available
The role of surgical tissue injury and intraoperative sympathetic activation in
postoperative immunosuppression after breast-conserving surgery versus
mastectomy: a prospective observational study.
Breast Cancer Res. 2024;26:42.
PubMed
Abstract available
Breast composition during and after puberty: the Chilean Growth and Obesity
Cohort Study.
Breast Cancer Res. 2024;26:45.
PubMed
Abstract available
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for
locally advanced/unresectable or metastatic HER2-negative breast cancer.
Breast Cancer Res. 2024;26:46.
PubMed
Breast cancer survivors suffering from lymphedema: What really do affect to
corporeality/body image? A qualitative study.
Breast Cancer Res. 2024;26:47.
PubMed
Abstract available
Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are
not associated with distant metastases.
Breast Cancer Res Treat. 2024 Mar 13. doi: 10.1007/s10549-024-07260.
PubMed
Abstract available
Immediate and delayed risk of breast cancer associated with classic lobular
carcinoma in situ and its variants.
Breast Cancer Res Treat. 2024 Mar 12. doi: 10.1007/s10549-024-07261.
PubMed
Abstract available
Infertility and risk of postmenopausal breast cancer in the women's health
initiative.
Breast Cancer Res Treat. 2024 Mar 9. doi: 10.1007/s10549-024-07257.
PubMed
Abstract available
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune
checkpoint blockade efficacy in triple-negative breast cancer by affecting the
immune microenvironment.
Cancer. 2024 Mar 14. doi: 10.1002/cncr.35270.
PubMed
Abstract available
Improving lifestyle behaviors during chemotherapy for breast cancer: The
Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) Trial.
Cancer. 2024 Mar 12. doi: 10.1002/cncr.35280.
PubMed
Abstract available
Interrogation of endothelial and mural cells in brain metastasis reveals key
immune-regulatory mechanisms.
Cancer Cell. 2024;42:378-395.
PubMed
Abstract available
Unlocking c-MET: A comprehensive journey into targeted therapies for breast
cancer.
Cancer Lett. 2024 Mar 8:216780. doi: 10.1016/j.canlet.2024.216780.
PubMed
Abstract available
Endogenous pAKT activity is associated with response to AKT inhibition alone and
in combination with immune checkpoint inhibition in murine models of TNBC.
Cancer Lett. 2024;586:216681.
PubMed
Abstract available
ACSL4-mediated membrane phospholipid remodeling induces integrin beta1 activation to
facilitate triple-negative breast cancer metastasis.
Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-23-2491.
PubMed
Abstract available
Stromal Type I Collagen in Breast Cancer: Correlation to Prognostic Biomarkers
and Prediction of Chemotherapy Response.
Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00053.
PubMed
Abstract available
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A
Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
Clin Breast Cancer. 2024 Feb 22:S1526-8209(24)00051.
PubMed
Abstract available
Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant
Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer.
Clin Breast Cancer. 2024 Feb 22:S1526-8209(24)00052.
PubMed
Abstract available
Avoiding Locoregional Overtreatment in Older Adults With Early-Stage Breast
Cancer.
Clin Breast Cancer. 2024 Feb 13:S1526-8209(24)00042.
PubMed
Abstract available
Impact of Anti-Estrogen Therapy on Early Cardiovascular Referrals, Tests and
Medications in Premenopausal Women with Operable Breast Cancer.
Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00044.
PubMed
Abstract available
Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of
Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In
Situ.
Clin Breast Cancer. 2024 Feb 5:S1526-8209(24)00040.
PubMed
Abstract available
Cell-free DNA concentration as a biomarker of response and recurrence in
HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Clin Cancer Res. 2024 Mar 12. doi: 10.1158/1078-0432.CCR-23-2928.
PubMed
Abstract available
Tumor-infiltrating lymphocytes refine outcomes in triple-negative breast cancer
treated with anthracycline-free neoadjuvant chemotherapy.
Clin Cancer Res. 2024 Mar 11. doi: 10.1158/1078-0432.CCR-24-0106.
PubMed
Abstract available
The movement of mitochondria in breast cancer: internal motility and
intercellular transfer of mitochondria.
Clin Exp Metastasis. 2024 Mar 15. doi: 10.1007/s10585-024-10269.
PubMed
Abstract available
Longitudinal adherence to surveillance for late effects of cancer treatment: a
population-based study of adult survivors of childhood cancer.
CMAJ. 2024;196:E282-E294.
PubMed
Abstract available
Disease-free survival as a surrogate for overall survival in HR+/HER2- early
breast cancer: A correlation analysis.
Eur J Cancer. 2024;202:113977.
PubMed
Abstract available
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors:
Dose escalation and expansion part of a multicenter open-label phase I trial
(SAKK 65/16).
Eur J Cancer. 2024;201:113588.
PubMed
Abstract available
Real-world data on malignant and borderline phyllodes tumors of the breast: A
population-based study of all 921 cases in the Netherlands (1989 -2020).
Eur J Cancer. 2024;201:113924.
PubMed
Abstract available
Evaluation of traditional targeted axillary dissection eligibility criteria for
node-positive breast cancer after neoadjuvant chemotherapy in a prospective
multicenter registry.
Eur J Surg Oncol. 2024;50:108245.
PubMed
Abstract available
MR-contrast enhanced mammography (CEM) for follow-up of breast cancer patients: a
"pros and cons" debate.
Eur Radiol. 2024 Mar 15. doi: 10.1007/s00330-024-10684.
PubMed
Abstract available
Systematic analysis of PANoptosis-related genes identifies XIAP as a functional
oncogene in breast cancer.
Gene. 2024 Mar 9:148355. doi: 10.1016/j.gene.2024.148355.
PubMed
Abstract available
Digital pathology for reporting histopathology samples, including cancer
screening samples - definitive evidence from a multisite study.
Histopathology. 2024;84:847-862.
PubMed
Abstract available
Improving the diagnosis of ductal carcinoma in situ with microinvasion without
immunohistochemistry: An innovative method with H&E-stained and multiphoton
microscopy images.
Int J Cancer. 2024;154:1802-1813.
PubMed
Abstract available
Health utility values of breast cancer treatments and the impact of varying
quality of life assumptions on cost-effectiveness.
Int J Cancer. 2024 Mar 13. doi: 10.1002/ijc.34899.
PubMed
Abstract available
Tumor Contact with Internal Mammary Perforator Vessels as Risk Factor for Gross
Internal Mammary Lymph Node Involvement in Breast Cancer Patients.
Int J Radiat Oncol Biol Phys. 2024 Mar 6:S0360-3016(24)00339.
PubMed
Abstract available
ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis
through activation of NRF2.
J Clin Invest. 2024;134:e171166.
PubMed
Abstract available
Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in
Curable Cancers.
J Clin Oncol. 2024 Mar 13:JCO2302763. doi: 10.1200/JCO.23.02763.
PubMed
Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal
Growth Factor Receptor 2-Negative Metastatic Breast
Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update.
J Clin Oncol. 2024 Mar 13:JCO2400248. doi: 10.1200/JCO.24.00248.
PubMed
Abstract available
What About This IDEA: The PROSPECT That Occult Malignant Lesions May Explain
Local Recurrences in Very Early Breast Cancer?
J Clin Oncol. 2024 Mar 15:JCO2302729. doi: 10.1200/JCO.23.02729.
PubMed
Predicting five-year interval second breast cancer risk in women with prior
breast cancer.
J Natl Cancer Inst. 2024 Mar 11:djae063. doi: 10.1093.
PubMed
Abstract available
Familial adversity: association with discontinuation of adjuvant hormone therapy
and breast cancer prognosis.
J Natl Cancer Inst. 2024 Mar 12:djae061. doi: 10.1093.
PubMed
Abstract available
Managing menopause after cancer.
Lancet. 2024;403:984-996.
PubMed
Abstract available
The promise of AI in personalized breast cancer screening: are we there yet?
Nat Rev Clin Oncol. 2024 Mar 12. doi: 10.1038/s41571-024-00877.
PubMed
Circulating tumor DNA validity and potential uses in metastatic breast cancer.
NPJ Breast Cancer. 2024;10:21.
PubMed
Abstract available
Deep learning radiomics based prediction of axillary lymph node metastasis in
breast cancer.
NPJ Breast Cancer. 2024;10:22.
PubMed
Abstract available
'Eczematous' dermatitis of the nipple: clinical and histopathological
differential diagnosis of Paget disease.
Pathology. 2024;56:300-312.
PubMed
Abstract available
Comparison of an amplicon-based large panel next generation sequencing (NGS)
assay with conventional testing methods for MET and HER2 amplification in lung
and breast cancers.
Pathology. 2024;56:325-333.
PubMed
Abstract available
Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for
early-stage breast cancer patients with HER2+ in Vietnam.
PLoS One. 2024;19:e0300474.
PubMed
Abstract available
A randomised controlled trial of Pre-Operative Oncotype DX testing in early-stage
breast cancer (PRE-DX study) - Study protocol.
PLoS One. 2024;19:e0300339.
PubMed
Abstract available
Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the
Luminal A Breast Cancer.
PLoS One. 2024;19:e0299571.
PubMed
Abstract available
Thank you for your interest in scientific medicine.